B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with Dasatinib in cutaneous T-cell lymphoma (CTCL)
Research output: Contribution to journal › Journal article › Research › peer-review
Original language | English |
---|---|
Journal | Leukemia |
Volume | 28 |
Pages (from-to) | 2109-12 |
Number of pages | 4 |
ISSN | 0887-6924 |
DOIs | |
Publication status | Published - 12 Jun 2014 |
ID: 117551379